Integration by design
- 5 May 2003
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (10) , 5586-5588
- https://doi.org/10.1073/pnas.1031802100
Abstract
As goes history, so goes research: this year, activity in areas of retrovirus research related only indirectly have provoked events that are notable when considered together. Last summer it was reported that a patient in one X-linked severe combined immunodeficiency retroviral vector gene therapy trial had developed leukemia. Now disquietingly, there has been a second such event, and a third patient is reported to have a vector insertion near the same gene (LMO2) as observed in the other two individuals (1). Meanwhile, in a basic research laboratory, experiments have moved us another step closer to understanding the mechanics of insertion specificity for retrovirus-type integrases (IN). As reported in this issue of PNAS, investigators have produced active retroviruslike elements with synthetic insertion specificities (2). Dan Voytas and colleagues at Iowa State University (Ames) study the Saccharomyces long terminal repeat (LTR)-retrotransposon Ty5, which targets heterochromatic regions (3). Now, in an elegant adaptation of the two-hybrid system, the 6-aa Ty5 targeting domain (TD) was exchanged for two heterologous domains shown to mediate interaction of their respective proteins with protein partners. When domains from those partners were produced fused to the LexA DNA-binding domain, targeting to LexA-binding sites was observed. Although integration specificity in the system was by no means absolute, these results are of interest to genetic engineers and future gene therapists. Interest in the integration patterns of retroviruses is longstanding. Despite the potential danger of deleterious activating or even inactivating insertions, retroviruses present compelling advantages as therapy vectors (reviewed in ref. 4). Early investigations of oncogenic retrovirus insertion sites in transformed cells showed that insertions were linked to activation of flanking oncogenes or DNaseI hypersensitive sites, leading to the notion that insertion into open chromatin was favored (reviewed in ref. 5; see also refs. 6 and 7). The potential for deleterious …Keywords
This publication has 60 references indexed in Scilit:
- RAC Hears a Plea for Resuming Trials, Despite Cancer RiskScience, 2003
- HIV-1 Integration in the Human Genome Favors Active Genes and Local HotspotsCell, 2002
- Correct Integration Mediated by Integrase–LexA Fusion Proteins Incorporated into HIV-1Molecular Therapy, 2002
- A Truncation Mutant of the 95-Kilodalton Subunit of Transcription Factor IIIC Reveals Asymmetry in Ty3 IntegrationMolecular and Cellular Biology, 2001
- Integrating DNA: Transposases and Retroviral IntegrasesAnnual Review of Microbiology, 1999
- A Preferred Target DNA Structure for Retroviral Integrasein VitroJournal of Biological Chemistry, 1998
- The Saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci.Genes & Development, 1996
- Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequencesCell, 1993
- Yeast retrotransposon revealedNature, 1992
- Mechanism of transposition of bacteriophage Mu: structure of a transposition intermediateCell, 1985